Tamsulosin
- TRADE NAMES: Flomax (Boehringer Ingelheim); Jalyn (GSK)
- INDICATIONS: Benign prostatic hypertrophy
- CLASS: Adrenergic alpha-receptor antagonist
- HALF-LIFE: 9–13 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alpha adrenergic blockers, Cimetidine, Conivaptan, Darunavir, Delavirdine, Erythromycin, Indinavir, Ketoconazole, Paroxetine Hydrochloride, Phosphodiesterase 5 inhibitors, Tadalafil, Telithromycin, Terbinafine, Vardenafil, Voriconazole, Warfarin
PREGNANCY CATEGORY: B
not indicated for use in women; Jalyn is pregnancy category X
Jalyn is tamsulosin and dutasteride.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric